Hemophilia
150
20
28
82
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Published Results
12 trials with published results (8%)
Research Maturity
82 completed trials (55% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.3%
8 terminated out of 150 trials
91.1%
+4.6% vs benchmark
10%
15 trials in Phase 3/4
15%
12 of 82 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 82 completed trials
Clinical Trials (150)
Haemophilia and Bone Loss - PHILEOS Study
Chronic Pain and Hemophilia
Effectiveness of an Adapted Physical Activity Program for Subjects Suffering From Haemophilia
A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B
Low-Cost Platelet-Rich Plasma for Hemarthropathy
Effects of Photobiomodulation in Hemophilia Patients.
A Study to Investigate the Course of Synovial Hypertrophy in Patients With Haemophilia A on Efanesoctocog Alfa Prophylaxis
Adult and Adolescent Hemophilia Patients Treated With Marstacimab: a Patient Experience Registry
Canadian CHO-KLAT/H-FIT Study - Quality of Life of, and Burden of Caring for, Persons With Hemophilia
Phase III Clinical Trial of STSP-0601 for Injection in Hemophilia Patients
ATHNdataset Registry
Central Pain Mechanisms and Clinical and Psychological Factors Associated With Pain Interference in Daily Life in Adults With Hemophilia and Hemophilic Arthropathy
Blood Flow Restriction in Improving Muscle Strength of Patients With Hemophilic Ankle Arthropathy
Monitoring of Anti-TFPI in Hemophilia
EPOCH-Economics and Patient Outcomes in China in Haemophilia
3D Ultrasound in Hemophilic Ankles
Validity and Reliability of the Two-minute Step Test in Hemophilia
Incidence of Ultrasonographically Detected Articular Damage in Initially Healthy Joints of Patients With Hemophilia A Receiving Prophylactic Treatment With Emicizumab
Central Sensitisation in Patients With Haemophilia and Degenerative Arthropathy
Effectiveness of an Educational Program for Pain Management in Patients With Hemophilic Arthropathy